Read next
Announcing the COVID-19 Therapeutics Accelerator
We are joining forces with Wellcome and Mastercard to beef up our COVID-19 response—backed by $125 million in both new funding and money already earmarked to tackle this epidemic. The expertise of pharmaceutical companies will be critical to this endeavor, named the COVID-19 Therapeutics Accelerator
Identifying therapeutics: The role of COVID-19 Therapeutics Accelerator
Monalisa Chatterji, a senior program officer for the Bill & Melinda Gates Foundation's Discovery & Translational Sciences team, works on the discovery of novel candidate therapeutics.